EW - Company ID 0001099800
The table below shows Edwards Lifesciences Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.45B | $2.69B | $3.27B | $3.14B | $3.68B | $1.64B |
| Short-term investments | $1.23B | $1.16B | $789.40M | $757.90M | $769.70M | $345.30M |
| Receivables | $775.70M | $693.30M | $697.00M | $669.20M | $716.00M | $778.30M |
| Inventory | $1.12B | $1.14B | $1.14B | $1.11B | $1.10B | $1.02B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $6.23B |
| $6.36B |
| $6.58B |
| $6.21B |
| $6.73B |
| $4.52B |
| Property, plant & equipment | $1.82B | $1.74B | $1.73B | $1.70B | $1.68B | $1.64B |
| Goodwill | $1.82B | $1.77B | $1.78B | $1.78B | $1.61B | $1.15B |
| Total assets | $13.32B | $13.27B | $13.49B | $13.02B | $12.97B | $10.10B |
| Accounts payable | $181.10M | $165.00M | $162.10M | $172.40M | $172.80M | $185.90M |
| Total current liabilities | $1.41B | $1.59B | $1.40B | $1.39B | $1.94B | $1.22B |
| Long-term debt | $598.50M | $598.20M | $598.00M | $597.80M | $597.50M | $597.30M |
| Total liabilities | $2.99B | $3.07B | $2.88B | $2.83B | $3.36B | $2.59B |
| Retained earnings | $14.62B | $14.15B | $13.86B | $13.53B | $12.78B | $9.71B |
| Total equity | $10.33B | $10.21B | $10.55B | $10.13B | $9.55B | $7.44B |